E-Learning

Veteran trader Stephen 'Sarge' Guilfoyle is placing his bets on a familiar technology name in 2025.

LMT's 320-day moving average has acted as a springboard in the past

RAPT Therapeutics, Inc. (NASDAQ:RAPT) shares are trading higher after the company disclosed a partnership with Shanghai Jemincare Pharmaceutical. The collaboration is for an exclusive license agreement to develop and commercialize RPT904, a novel anti-IgE monoclonal antibody worldwide, excluding mainland China, Hong Kong, Macau, and Taiwan. RPT904 is designed to provide a potential alternative to omalizumab (Xolair), addressing allergic conditions such as asthma and chronic spontaneous urticaria

Playa Hotels' shares surged Monday after the resort operator said it has entered into an agreement to explore a potential acquisition by Hyatt Hotels.

The video platform said it will use the infusion of $250 million to support its growth. Rumble stock has mostly struggled to gain traction since its debut in 2022.

Here's what you need to know about whether U.S. stock markets will be open or closed on Christmas Eve this year.

Xerox said it was purchasing privately held Lexmark International from its Chinese owners for $1.5 billion to meet the needs of clients in the hybrid workplace.

The Santa Claus Rally could get off to a late start this year. But better late than never.

(Bloomberg) -- It’s been a banner year for high-yield municipal bonds, and in particular the category’s star money manager, John Miller, who joined First Eagle Investments in January after nearly three decades at Nuveen.Most Read from BloombergHo Chi Minh City Opens First Metro Line After Years of DelayThe Architects Who Built MiamiReviving a Little-Known Modernist Landmark in BuffaloNew York’s Congestion Pricing Plan Still Faces Legal HurdlesNew York City’s Historic Preservation Movement Is Hav

Shares of Palantir Technologies, MicroStrategy, and Axon Enterprise traded lower in their first day on the Nasdaq 100 index.